Back

Cases and Conversations-Evolving Radiation Strategies in HER2-Positive Breast Cancer: Early-Stage Through Metastatic Disease

This online, on-demand virtual symposium brings together a multidisciplinary panel of breast cancer experts to translate evolving HER2-directed systemic therapy and radiation science into practical strategies for real-world care. Through case-based presentations and expert panel discussions with integrated data summaries, faculty deliver actionable guidance on integrating radiation with ADC-based therapy across early-stage and metastatic settings, managing overlapping pulmonary and cardiac toxicities, using recent and emerging trial data to appropriately escalate or de-escalate radiation, and coordinating multidisciplinary management of brain metastases and oligoprogressive disease. This dynamic program is designed to equip radiation oncologists and the broader care team to confidently and safely integrate local and systemic therapy across the HER2-positive continuum. This educational activity is an archive of the live symposium held on September 27, 2026.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • includes On-demand / recorded video
  • Credit · Up to 1.5 credits
  • Commercial Support
  • Released
    Oct 8, 2026
  • Last day to claim credit
    Oct 9, 2027 12 months left